Comment on CMS-2026-1255-0001

Summary: The American Medical Group Association (AMGA) supports the proposed rule to include drugs in interoperability and prior authorization frameworks but urges CMS to shorten decision timeframes to 24 hours and implement a default-to-approval policy for missed deadlines. They also recommend extending API access to out-of-network providers with care relationships, establishing a "Gold Carding" framework for high-performing providers, and setting minimum content standards for denial notices.